1h Free Analyst Time
The insulin syringes market is forecasted to grow by USD 388 million during 2023-2028, accelerating at a CAGR of 4.5% during the forecast period. The report on the insulin syringes market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rising global burden of diabetes, favorable government initiatives, and availability of diabetes self-management education programs.
The insulin syringes market is segmented as below:
By Disease Type
- Type 2 diabetes
- Type 1 diabetes
By Geographical Landscape
- North America
- Europe
- APAC
- South America
- Middle East and Africa
The report on the insulin syringes market covers the following areas:
- Insulin syringes market sizing
- Insulin syringes market forecast
- Insulin syringes market industry analysis
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
Table of Contents
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Disease Type
7 Customer Landscape
8 Geographic Landscape
9 Drivers, Challenges, and Opportunity/Restraints
10 Competitive Landscape
11 Competitive Analysis
12 Appendix
360 degree market analysis
List of Exhibits
Executive Summary
The following companies are recognized as the key players in the global insulin syringes market: AdvaCare Pharma, ASP Healthcare Pty Ltd., Avantor Inc., B.Braun SE, Becton Dickinson and Co., Cardinal Health Inc., CODAN Medizinische Gerate GmbH and Co KG, Gerresheimer AG, Healthwarehouse.com Inc., Hi Tech Medics Pvt Ltd., Hindustan Syringes and Medical Devices Ltd., LAC Healthcare Solutions, Nipro Corp., Novo Nordisk AS, Poly Medicure Ltd., SCHOTT AG, Smiths Group Plc, Terumo Corp., Thermo Fisher Scientific Inc., and UltiMed Inc..Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is increase in awareness programs for diabetes."
According to the report, one of the major drivers for this market is the rising global burden of diabetes.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- AdvaCare Pharma
- ASP Healthcare Pty Ltd.
- Avantor Inc.
- B.Braun SE
- Becton Dickinson and Co.
- Cardinal Health Inc.
- CODAN Medizinische Gerate GmbH and Co KG
- Gerresheimer AG
- Healthwarehouse.com Inc.
- Hi Tech Medics Pvt Ltd.
- Hindustan Syringes and Medical Devices Ltd.
- LAC Healthcare Solutions
- Nipro Corp.
- Novo Nordisk AS
- Poly Medicure Ltd.
- SCHOTT AG
- Smiths Group Plc
- Terumo Corp.
- Thermo Fisher Scientific Inc.
- UltiMed Inc.
